Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0052 | 1 | 1 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0019 | 0.0451 | 0.0451 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0019 | 0.0451 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0052 | 1 | 1 |
Trypanosoma brucei | protein kinase, putative | 0.0052 | 1 | 1 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.0052 | 1 | 1 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.0052 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0019 | 0.0451 | 0.5 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.0052 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0052 | 1 | 1 |
Onchocerca volvulus | 0.0018 | 0 | 0.5 | |
Echinococcus granulosus | mitogen activated protein kinase | 0.0052 | 1 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0034 | 0.4797 | 0.4797 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0019 | 0.0451 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.005 | 0.9395 | 0.9395 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0019 | 0.0451 | 0.0451 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0019 | 0.0451 | 0.5 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.0052 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.4797 | 0.4797 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.005 | 0.9395 | 0.9395 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0052 | 1 | 1 |
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.0451 | 0.0451 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.0052 | 1 | 1 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0019 | 0.0451 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0052 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0052 | 1 | 1 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0052 | 1 | 1 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0019 | 0.0451 | 0.0451 |
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.0451 | 0.0451 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.005 | 0.9395 | 0.9395 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0019 | 0.0451 | 1 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.0052 | 1 | 1 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.0052 | 1 | 1 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0019 | 0.0451 | 0.5 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0019 | 0.0451 | 0.0451 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0019 | 0.0451 | 0.0451 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.0052 | 1 | 1 |
Giardia lamblia | Kinase, CMGC MAPK | 0.0052 | 1 | 1 |
Toxoplasma gondii | exonuclease III APE | 0.0019 | 0.0451 | 0.0451 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0019 | 0.0451 | 0.0451 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0019 | 0.0451 | 0.0451 |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.0052 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.9395 | 0.9395 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.0052 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.4797 | 0.4797 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -4.602 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.602 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.602 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.602 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.602 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.602 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.602 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.602 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | = 4.6 | Growth inhibition of human CCRF-CEM cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human K562 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human MOLT4 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human SR cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human A549 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human EKVX cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human HOP18 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human HOP62 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human HOP92 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human NCI-H226 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human NCI-H23 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human NCI-H322M cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human NCI-H460 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human NCI-H522 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human DMS273 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human COLO205 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human DLD1 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human HCC2998 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human HCT116 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human HCT15 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human HT29 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human KM12 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human KM20L2 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human SW620 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human SF268 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human SF295 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human SF539 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human SNB19 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human SNB75 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human U251 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human XF498 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human LOX IMVI cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human MALME-3M cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human M14 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human M19-MEL cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human SK-MEL-2 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human SK-MEL-28 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human SK-MEL-5 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human UACC257 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human UACC62 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human IGROV1 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human SK-OV-3 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human 786-0 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human A498 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human ACHN cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human CAKI1 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human RFX393 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human SN12C cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human TK10 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human UO31 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human PC3 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human DU145 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human MCF7 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human MDA-MB-231 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human HS578T cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human MDA-MB-435 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human MDA-N cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human BT549 cells | ChEMBL. | 10924160 |
GI50 (functional) | = 4.6 | Growth inhibition of human T47D cells | ChEMBL. | 10924160 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.